🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to evaluate the safety and tolerability of clesrovimab comp...
Status
Completed
Location
Miller Children's & Women's Hospital Long Beach ( Site 0001)
Start Date
2021-11-30
Trial ID
NCT04938830
Treatments Being Tested
The primary and secondary objectives of this Phase 1 study are respectively...
Status
Completed
Location
Centre for Vaccinology (CEVAC)
Start Date
2020-09-07
Trial ID
NCT04519073
Treatments Being Tested
This was a non-interventional, prospective, multi-center study with no cont...
Status
Completed
Location
Multiple Locations
Start Date
2014-10
Trial ID
NCT02282982
Phase II, randomized, safety and efficacy study in recurrent/metastatic bre...
Status
Terminated
Location
Baptist Cancer Institute
Start Date
2013-04-04
Trial ID
NCT01703754
Treatments Being Tested
The purpose of this study is to measure the rate of anti-palivizumab antibo...
Status
Completed
Location
Birmingham Pediatric Associates
Start Date
2005-10
Trial ID
NCT00233064
Treatments Being Tested
Published data by the Organización panamericana de la Salud shows that Peru...
Status
Completed
Location
Site Reference ID/Investigator# 27834
Start Date
2007-09
Trial ID
NCT01107535
This is a small study known as a pilot study. This pilot study is being don...
Status
Completed
Location
Surrey Memorial Hospital
Start Date
2007-11
Trial ID
NCT00484393
Treatments Being Tested
The primary objective of the study is to determine whether the incidence of...
Status
Completed
Location
Multiple Locations
Start Date
2010-07
Trial ID
NCT01545245
The primary objective of this study was to compare the safety and efficacy ...
Status
Completed
Location
University Of Alabama At Birmingham
Start Date
2004-11
Trial ID
NCT00129766
Treatments Being Tested
The hypothesis of the present study is that the prophylaxis with palivizuma...
Status
Completed
Location
Tokyo Women's Medical University
Start Date
2008-03
Trial ID
NCT01072552